Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220) - Image 1

£75.66

Springer Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Name: Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)
Brand: Springer
Price: 75.65 GBP
Availability: InStock

Medical Technology

Price History & Forecast

Last 36 days • 36 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 36 days • 1 price levels

Days at Price

Price Analysis

Most common price: £76 (36 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 36 days

Description

This book is aimed to summarise the key aspects of the role of circulating tumour cells (CTCs) in breast cancer, with special attention to their contribution to tumour progression and establishment of metastatic disease. We aim to give a clear overview of the knowledge about CTCs, framed in the context of breast cancer, by analysing basic and clinical research carried out so far. In a broader sense, we will address what are the main clinical needs of this disease based on its molecular heterogeneity (subtypes) and lay out the knowledge and understanding that CTCs are giving about it and how they are contributing and can still improve the better monitoring and management of breast cancer patients. We will discuss the evidences of the use of CTCs as a tool to monitor cancer progression and therapy response, based on the prognostic and predictive value they have, as well as a tool to unravel mechanisms of resistance to therapy and to identify new biomarkers allowing to predict therapy success. Moreover, we will analyse the main aspects of ongoing clinical trials and how they can contribute to determine the clinical utility of CTCs as a breast cancer biomarker. We will also touch upon general knowledge or basic notions of the biology of the metastatic process in epithelial cancers, in order to understand the origin and biology of CTCs. In this sense, we will pay special attention to EMT (epithelial to mesenchymal transition), dormancy and minimal residual disease, three key aspects that determine the outcome of the disease. We will also cover general aspects on the isolation and characterization techniques applies to the study of CTCs, and also the possibilities that the study of CTCs, as a biomarker with biological function, is opening in terms of understanding the biology of metastatic cells and the identification of therapeutic targets based on the functional and molecular characterization of CTCs. Lastly, we will try to foresee the future of CTCs in terms of clinical application and implementation in the clinical routine.

Product Specifications

Brand: Springer
Format: Paperback
ASIN: 3030358070
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Medical Technology
Domain: Amazon UK
Release Date: 18 April 2021
Listed Since: 22 March 2021

Barcode

No barcode data available

Springer Circulating Tumor Cells in Breast Cancer Metastatic Disease: 1220 (Advances in Experimental Medicine and Biology, 1220)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Circulating Tumor Cells (CTCs): Detection Methods, Health Impact & Emerging Clinical Challenges

Experimental and Clinical Metastasis: A Comprehensive Review

Breast Cancer Metastasis and Drug Resistance: Challenges and Progress: 1152 (Advances in Experimental Medicine and Biology, 1152)

Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Experimental Metastasis: Modeling and Analysis

Springer - Minimal Residual Disease and CTCs in Breast Cancer

Techniques and Methodological Approaches in Breast Cancer Research

Isolation and Molecular Characterization of Circulating Tumor Cells: 994 (Advances in Experimental Medicine and Biology, 994)

Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Bone Cancer: Progression and Therapeutic Approaches

Genomic Instability and Cancer Metastasis: Mechanisms, Emerging Themes, and Novel Therapeutic Strategies: 20 (Cancer Metastasis - Biology and Treatment, 20)

From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)

Intercellular Communication in Cancer

Advances in Cancer Biomarkers: From biochemistry to clinic for a critical revision: 867 (Advances in Experimental Medicine and Biology, 867)

Springer Cell Biology and Translational Medicine Volume 13

Stem Cell Therapeutics for Cancer

Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics (Contemporary Cancer Research)

New Developments in Metastasis Suppressor Research

Translational Research in Breast Cancer: 1187 (Advances in Experimental Medicine and Biology, 1187)

Molecular Pathology of Breast Cancer

Metastatic Cell: Behaviour and biochemistry